News tagged with amgen inc
Topical use of arthritis drug provides relief for dry eye disease
Dry eye disease (DED) is a common condition that causes discomfort, visual disturbance and potentially damaging ocular surface inflammation that greatly impacts a person's quality of life. An estimated nine million people ...
Ophthalmology
Apr 18, 2013 |
4 / 5 (1) |
0
Novel Amgen virus-vaccine shrinks melanoma tumors
Shares of drugmaker Amgen Inc. are rising on news its innovative melanoma drug, which uses a virus as a Trojan horse to infiltrate and destroy tumors, shrank far more tumors than a standard treatment in a late-stage test.
Cancer
Mar 20, 2013 |
not rated yet |
0
Researchers discover way to block body's response to cold
Researchers at St. Joseph's Hospital and Medical Center in Phoenix, Arizona, in collaboration with Amgen Inc. and several academic institutions, have discovered a way to block the body's response to cold using a drug. This ...
Neuroscience
Mar 01, 2012 |
5 / 5 (1) |
0
|
Amgen to pay record $762 mn fine over anemia drug (Update)
US pharmaceutical giant Amgen has pleaded guilty to illegally introducing a mislabeled drug for treating anemia onto the market and will pay a record $762 million fine, officials said Wednesday.
Medications
Dec 18, 2012 |
5 / 5 (1) |
0
US halts Amgen study after teen patient death (Update)
U.S. government health regulators have halted Amgen's studies of its drug Sensipar after the death of a 14-year-old patient in a company trial.
Medications
Feb 26, 2013 |
not rated yet |
0
Amgen 4Q profit drops 16 pct. on higher spending
Drugmaker Amgen Inc. on Wednesday posted a 16 percent drop in fourth-quarter profit, as higher costs for production, marketing, research and other items offset higher sales for many of its biologic medicines. The results ...
Other
Jan 23, 2013 |
not rated yet |
0
Amgen buying deCODE Genetics for $415 million
Biotech pioneer Amgen Inc., in a bid for a big edge in using people's genetic information to find better ways to attack diseases, is buying human genetics research and analytics leader deCODE Genetics for $415 million.
Genetics
Dec 10, 2012 |
not rated yet |
0
